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Abstract  
Background: Sniff nasal inspiratory pressure (SNIP) is a non-invasive measure of 
inspiratory muscle function often used as an outcome measure in clinical studies. An initial 
period of familiarisation with the test is recommended to minimise the learning effect. The 
repeatability of SNIP in patients with chronic obstructive pulmonary disease (COPD) is 
currently unknown.  
Objectives: The aim of this study was to assess the between-session repeatability of SNIP 
over a three-week period, in moderate to severe COPD patients and compare it with that of 
maximal inspiratory and expiratory pressure (PImax and PEmax respectively).  
Methods: Twenty one patients (13M) with mean FEV1 38% predicted (SD:15), 
FEV1/FVC%: 34.3 (SD:10.4), performed SNIP and PImax and PEmax manouevres on three 
different sessions (S1, S2 and S3), 3-7 days apart. SNIP was performed at functional residual 
capacity (FRC), PImax was performed at FRC and at residual volume (RV) to explore 
volume-dependent differences in the learning effect between sessions and PEmax from total 
lung capacity (TLC).  
Results: The intra-class correlation coefficient (ICC) for SNIP was the highest of the three 
measures (S1-S3 ICC (95% CI) SNIP: 0.96 (0.88 to 0.94); PImax at FRC 0.82 (0.63 to 0.92); 
PImax at RV: 0.89 (0.78 to 0.95); PEmax: 0.96 (0.92 to 0.98) and had the lowest mean 
change between sessions [mean (p value) S2-S1: 2.1(0.4) and S3-S2: -0.3(0.9)].   
Conclusions: SNIP is repeatable over a period of 3 weeks in medically stable, moderate to 
severe COPD patients. In our study, two sessions were adequate to learn how to perform the 
test.  
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Introduction 
Respiratory muscle function tests are often used in clinical practice to assess respiratory 
muscle weakness or to monitor change in respiratory muscle strength over time.  The most 
common tests are maximal inspiratory and expiratory pressure (PImax and PEmax) and sniff 
nasal inspiratory pressure (SNIP) [1]. These tests are relatively easy to perform and the 
development of portable devices has allowed their assessment in a variety of clinical settings.  
SNIP is a more natural manouevre than the PImax or PEmax manouevres [2] and is used as 
an outcome measure in clinical studies, such as in patients with degenerative neuromuscular 
disease [3, 4]
 
or chronic obstructive pulmonary disease (COPD) [5]. Due to its volitional 
nature, the SNIP, just like PImax and PEmax, requires a period of familiarization before 
baseline measurements are accepted.  In COPD, although values for SNIP have been reported 
[6], there is limited information about the repeatability of the measure.  
The repeatability of SNIP has been studied in healthy subjects [4, 7]. Maillard and colleagues 
[7] showed that the SNIP values obtained after one day were maintained after a period of one 
month and Terzi and colleagues [4] showed that SNIP had good reproducibility over two 
sessions a few days apart. The optimal number of sniffs per session has also been established 
in healthy subjects and a variety of patient groups [8] contributing to the standardisation of 
baseline assessments prior to clinical studies. However, there are currently no data on the 
between-session repeatability of SNIP in COPD patients.  
The aim of this study was to explore the between-session repeatability of SNIP over a period 
of three weeks in COPD patients and compare it with that of PImax and PEmax pressures.  
We also wished to establish how many practice sessions COPD patients need prior to 
entering an interventional study and to obtain information that would allow us to make 
sample size calculations for a longer repeatability study.   
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Methods 
Subjects 
The study was conducted as part of a larger rehabilitation study and participants were the first 
twenty one patients (13M: 8F) who were recruited in that study. Patients had moderate to 
severe COPD (FEV1/FVC < 70%, FEV1 < 60% predicted) and were recruited from outpatient 
clinics at King’s College Hospital, London and from South London British Lung Foundation 
Breathe Easy groups.  Data was collected in March 2000- March 2002 in the context of a 
larger rehabilitation study that was ongoing and registered in January 2004 (ISRCTN: 
19258620), before the 13
th
 September 2005 deadline set by the International Committee of 
Medical Journal Editors (ICMJE) for clinical trials registration.  
The inclusion criteria for the study were: positive smoking history, absence of exacerbations 
of COPD for at least 4 weeks prior to the initial session, and no change in medication for the 
same period. The exclusion criteria were: co-existing severe heart disease, hypertension or 
cor pulmonale and long term oral corticosteroid treatment due to its effect on inspiratory 
muscle function that could potentially influence our measurements [9].  The protocol was 
accepted by the local ethics committee and patients gave their informed consent. 
 
Study design and measurements 
Our COPD patients attended three laboratory-based sessions (S1, S2 and S3) three to seven 
days apart. On each session, patients performed SNIP, PImax and PEmax manoeuvres. 
Pressures were measured using Validyne MP45 differential pressure transducers (Validyne 
Corp, Northridge, CA, USA). The pressure signal from the pressure transducer was amplified 
by a carrier amplifier (Validyne Co., Northridge, CA, USA) and acquired on a Macintosh 
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PowerMac computer running Labview 4.1 software (National Instruments, Texas, USA).  
The same investigator performed the measurements on all sessions. In each session, the 
highest value for each measure was accepted for analysis as long as it was within 5% of the 
previous two highest values.   
Participants were naive to the investigations and performed the following tests: 
Lung function 
Lung function testing was performed on the first session only by senior clinical physiologists 
in the lung function department of King’s College Hospital. Measurements of forced 
expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) were obtained using a 
dry bellows spirometer (S Model, Vitalograph, Buckinghamshire, UK) while total lung 
capacity (TLC) and residual volume (RV) were measured by constant whole body 
plethysmography (Auto-link, Morgan Medical, Gillingham, Kent, UK). Blood gases were 
measured from arterialised ear lobe capillary samples (Rapidlab 248, Chiron, MA, USA).  
Sniff nasal pressure (SNIP) 
SNIP manoeuvres were performed from functional residual capacity (FRC) with patients in 
the sitting position. Each patient had custom-made nasal plugs made from dental putty and 
hand-fitted around the tip of an 80cm catheter connected to a pressure transducer (Validyne 
MP45, Validyne Corp., Northridge, CA, USA). Each nasal plug was kept in a named 
envelope for use in subsequent sessions. Patients were asked to perform a strong, sharp, 
maximal sniff. Pressure tracings were accepted for analysis if they had a smooth downstroke, 
a sharp peak and took a maximum of 400ms from baseline to peak. A minimum of 10 efforts 
were made with rest intervals of 30secs and the peak value was recorded.  Visual feedback 
and strong verbal encouragement was given throughout. 
Maximum inspiratory pressure (PImax) 
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Maximum inspiratory pressure was assessed from two lung volumes, functional residual 
capacity (FRC) and residual volume (RV),  using a flanged mouthpiece (PK Morgan Ltd, 
Rainham, UK) connected to a metal tube. A valve in the tube allowed normal breathing 
before maximal efforts were made and a separate hole in the tube ensured maintenance of an 
open glottis. The metal tube was connected to a differential pressure transducer (Validyne 
MP45, Validyne Corp., Northridge, CA, USA) and PImax tracings were recorded in real 
time. All patients were seated upright and encouraged to make maximal inspiratory efforts 
sustained for one second. Nose clips were worn at all times and patients performed a 
minimum of 10 efforts with rest intervals of 30-60 seconds between efforts. The peak value 
was recorded. Visual feedback and strong verbal encouragement was given throughout.  
Maximum expiratory pressure (PEmax) 
PEmax was assessed from total lung capacity (TLC) using the same equipment as for the 
PImax measurements.  Patients wore nose clips, had visual feedback and were given strong 
verbal encouragement throughout.  A minimum of 10 manoeuvres were performed and the 
peak pressure was recorded on each session.  
 
Statistical analysis 
Data were analysed under the null hypothesis that there were no differences in SNIP, PImax 
and PEmax between the 3 sessions.  Differences between sessions (S2-S1, S3-S2 and S3-S1) 
were analysed using a paired t-test and the intra-class correlation coefficient (ICC) was 
calculated for all 3 sessions. The significance level was set at 5%.  Data were analysed using 
SPSS (17.0) and graphs were created in Graph Pad Prism (version 3.03).   
 
Results 
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All patients tolerated the tests well. There were no complaints of pain or discomfort during 
the tests.  The baseline characteristics of study participants are presented in Table 1.  
 
Table 1: Anthropometric and spirometric characteristics of the study participants 
 
Gender (M/F) 13/8 
Age (years) 71.9 (10) 
MRC scale 3 (0.8) 
BMI (kg/m
2
) 26.4 (2.3) 
Pack years 69 (51) 
FEV1 (L) 0.9 (0.3) 
FEV1 (%pred.) 38 (15) 
FEV1/FVC (%) 34.3 (10.4) 
TLC(L) 6.5 (1.3) 
RV(L) 4.1 (1.2) 
TLC(%pred.) 117.2 (13.2) 
RV(%pred.) 180.5 (40.5) 
 
 
 
SNIP values were repeatable between sessions.  SNIP showed greater repeatability than 
PImax, especially following the second session (S2).  The mean SNIP value was consistently 
higher than PImax in each session, regardless of the lung volume the PImax measurements 
were assessed from (Figure 1). When the best value of all three sessions was considered, 
SNIP was (mean (SD) 72.21 (18.14) cmH2O while PImax at FRC was 64.60 (12.75) cmH2O 
and PImax at RV was 64.92 (13.88) cmH2O. Therefore the SNIP value was 11.8% higher 
than PImax at FRC and 11.2% higher than PImax at RV.  
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PImax at RV was more repeatable than PImax at FRC and tended to plateau after the second 
session (ICC 0.89 and 0.82 respectively). The intra-class correlation coefficient (ICC) for 
sessions 1 to 3 for PEmax was 0.96 and 0.94 respectively.   
A summary of the results is shown in Table 2.  
 
Table 2: Between-session repeatability of SNIP, PImax and PEmax  
Tests 
(cmH2O) 
Sessions 
mean(SD) 
 
Differences 
mean 
(p value) 
Intra-class 
Correlation 
Coefficient 
(ICC) 
(95% CI) 
 1 2 3 S2-S1 S3-S2 S3-S1 S1 to S3 
SNIP 65.69 
(15.65) 
67.78 
(18.06) 
67.49 
(20.25) 
2.1 
(0.4) 
-0.3 
(0.9) 
1.8 
(0.6) 
0.94 
(0.88 to 0.98) 
PImax/at 
FRC 
58.60 
(12.83) 
55.04 
(13.18) 
56.24 
(15.62) 
-3.6  
(0.2) 
1.2 
(0.7) 
-2.4 
(0.4) 
0.82 
(0.63 to 0.92) 
PImax/at 
RV 
57.60 
(11.72) 
60.04 
(16.13) 
58.95 
(13.50) 
2.4 
(0.4) 
-1.1 
(0.6) 
1.4 
(0.5) 
0.89 
(0.78 to 0.95) 
PEmax 90.41 
(28.47) 
91.73 
(28.81) 
92.96 
(31.30) 
1.3 
(0.7) 
1.2 
(0.7) 
2.6 
(0.3) 
0.96 
(0.92 to 0.98) 
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Figure 1: Repeated measures per test in COPD patients. Each data point represents the 
maximal value for each patient during the sessions. The horizontal lines represent the mean 
value of the group per session. 
 
 
DISCUSSION 
Volitional measures of respiratory muscle function are often used in clinical rehabilitation 
studies for sequential assessment of changes in muscle strength. The main advantage over 
their non-volitional equivalent is that they are easier to perform in a variety of clinical 
settings, such as in community studies, and avoid the need for insertion of balloon catheters 
[1] and possible patient discomfort.  However, they are influenced by motivation and patients 
may learn how to do the test better on each session.  The exploration of the between-session 
repeatability of these measures allows us to estimate how much of the change observed after 
a clinical study is due to the intervention under investigation or due to the learning effect.  
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The between-session reproducibility of SNIP has been studied in healthy subjects [4, 7].  
Terzi and colleagues [4] found the measure repeatable over a period of 2 weeks and more 
reproducible than PImax. Similarly, Mailard and colleagues [7] studied the SNIP over a 
period of a month and showed that it had good repeatability in healthy subjects.  The number 
of sniffs required to eliminate the learning effect on the same session has also been 
investigated by Lofaso and colleagues [8] who studied SNIP in patients with a variety of 
neuromuscular and respiratory diseases. The authors showed that more than 10 sniffs were 
required per session to achieve accurate SNIP measurements. To the best of our knowledge, 
the between-session repeatability of SNIP has not yet been investigated in COPD patients. 
This patient group is often reported to have functional inspiratory muscle weakness and the 
outcome of rehabilitation interventions that may affect the degree of dynamic hyperinflation, 
or respiratory muscle function can be evaluated by the non-invasive SNIP.  
 Our study showed that the SNIP was a repeatable measure in COPD patients who were free 
of exacerbations over a three week period. The test had better repeatability than PImax, 
regardless of the lung volume at which PImax was measured, and generated a higher group 
mean value (Figure 1).  
The better repeatability of SNIP could be attributed to the fact that the sniff is a more natural 
manoeuvre than the static PImax manoeuvre and is therefore rarely underperformed [2]. In 
COPD patients, SNIP has a disadvantage as a measure in that it underestimates slightly the 
more invasive sniff oesophageal pressure [6] but its non-invasive nature makes it an ideal test 
in non-laboratory based clinical studies.  In addition, SNIP improves diagnostic precision 
when used in tandem with PImax [12] or diaphragm twitch mouth pressure [13] and it is 
therefore important for the non-invasive assessment of respiratory muscle function. In our 
study, SNIP group values were consistently higher than the PImax values in each session. A 
similar result was observed when we identified the best value from all three sessions.  In 
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particular, SNIP values were 12% greater than PImax at FRC and 11% greater than PImax at 
RV.   The consistency in higher values of SNIP in our group suggests that this test is a 
valuable outcome measure for repeated measures in COPD patients who are participating in 
interventional studies or rehabilitation programmes. 
Our COPD patients performed a minimum of 10 SNIP manoeuvres per session and we 
recorded the maximum value from each session. Our results showed that the maximum value 
plateaued after the second session.  This suggests that two sessions, three to seven days apart, 
are adequate to minimise the learning effect from SNIP in COPD patients as long as more 
than 10 sniffs are performed per session.  
 
In contrast to previous studies, we did not observe a significant learning effect associated 
with the PImax and PEmax pressures.  PImax measurements have been reported to be 
sensitive to the learning effect due to the nature of the manouevre. In COPD patients, the 
learning effect of PImax and PEmax has been evaluated in a study by Larson and colleagues 
[10] over a period of 4 weeks. The authors suggested that a substantial amount of practice 
was required to learn to do the test but the number of manoeuvres per session were not 
specified. In addition, two researchers were used for the data collection although instructions 
were standardised. In our study, one experienced investigator performed the measurements in 
all three sessions.  It is possible that PImax measurements show greater repeatability between 
sessions if the same investigator is involved throughout the sessions. Future studies need to 
investigate the variation of results when experienced and novel researchers take the 
measurements.  
Equally, repeatability of the measure is influenced by the lung volume at which it is 
measured. PImax is conventionally measured at residual volume (RV) [1] as measurements 
are expected to be more repeatable from this minimal volume. Pressures generated at RV are 
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more negative than those measured at functional residual capacity (FRC) as the pressure 
reflects the contribution of the elastic recoil of the respiratory system as well as the optimal 
length and configuration of the inspiratory muscles [1].  Our results confirmed that the PImax 
value at RV was more negative than the pressure from FRC in most sessions but we found 
that both were repeatable, especially after the second session. When the best value of all three 
visits was considered, PImax at FRC was close to the PImax value at RV. This result could 
be attributed in part to the large number of practice manoeuvres each patient had to perform 
throughout the three sessions and the fact that only one investigator was performing the test.   
 
PEmax was also a repeatable measure in our study. The PEmax manoeuvre requires 
recruitment of the abdominal muscles that are usually activated during a cough.  Therefore, 
this manouevre is perhaps more natural than the PImax manouevre.  It is also well 
standardised as it is always performed from total lung capacity (TLC) [1]. Some studies, 
however, have shown less good repeatability, as in a study in non-CF bronchiectasis patients 
[14]. Moran and colleagues [14] found that PEmax increased significantly on their second 
session which was 10-14 days after the first one. In healthy subjects [11] and COPD patients 
[10] the repeatability and reproducibility of PEmax has been more consistent between 
sessions. The results of our study are in agreement with these studies and suggest that PEmax 
is highly repeatable in COPD patients over a period of three weeks and that two practice 
sessions are adequate for baseline measurements prior to clinical studies.  
 
 
Limitations of the study 
 
This study examined the repeatability of SNIP over a period of 3 weeks, aiming to determine 
the minimum number of practice sessions needed to minimise the learning effect prior to 
clinical studies. Clinical studies or rehabilitation programmes often take longer to complete, 
13 
 
usually 7-8 weeks. Therefore, results of this study may not be generalisable to longer periods 
of time. In addition, the sample size could not be determined in advance in our study, as there 
was limited information about the between session standard deviation for SNIP in COPD 
patients.  However,  based on the largest standard deviation of SNIP between sessions in our 
cohort (S3-S1, SD=17.14),  we estimated that a future study, would need 21 patients to 
explore the repeatability of SNIP over a longer period, with a 5% significance level and 80% 
power.  
Furthermore, the results of our study provide information about the repeatability but not the 
reproducibility of SNIP. In our study, the same investigator performed all assessments as we 
aimed to exclude between-investigator bias. However, clinical studies are often conducted in 
different sites and more than one investigator takes measurements of respiratory muscle 
function. Therefore, future studies need to establish the reproducibility of these measures 
over repeat sessions using more than one investigator and more than one setting.   
Finally, this study examined the repeatability of SNIP in patients with moderate to severe 
disease who were optimally managed and stable. The results may not apply to COPD patients 
in, for example, the early period of recovery after an exacerbation.  
 
 
CONCLUSION 
Sniff nasal pressure is a highly repeatable test over a period of three weeks in patients with 
moderate to severe COPD. Two repeat practice sessions are adequate to minimise the 
learning effect associated with SNIP prior to interventional studies, as long as more than ten 
attempts are performed in each session. In contrast to previous studies, we did not observe a 
significant learning effect for PImax and PEmax. 
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